Eli Lilly & Co. vs Summit Therapeutics Inc.
LLY vs SMMT — side-by-side comparison from reported financials. LLY leads 4, SMMT leads 1 of 5 comparable metrics.
Eli Lilly & Co.
LLY · Healthcare
$1 177.20+0.65%Solid
Summit Therapeutics Inc.
SMMT · Healthcare
$17.55+2.21%Strained
| Metric | LLY | SMMT |
|---|---|---|
| Price | $1 177.20 | $17.55 |
| Market cap | $1.05T | $14.0B |
| Revenue (TTM) | $79.7B | — |
| Revenue growth | +31.7% | — |
| Net margin | 33.5% | — |
| Free cash flow | $18.2B | -$932M |
| Net cash (debt) | ($35.2B) | $670M |
| 1-year price return | +37.6% | -22.5% |
| P/E | 41.6 | — |
| P/E vs own history (cheap-side %) | 88% | — |
| Dividend yield | 0.52% | — |
| Return on equity | 93% | -169% |
| Altman Z-score | 7.10 | — |
| CV checks passed | 11 of 11 | 3 of 11 |
| Employees | 50,000 | 265 |
Full résumé-style profiles: LLY CV · SMMT CV
Green marks the stronger side on comparable metrics. Figures are derived from company filings and may be delayed, restated or incomplete — information, not investment advice.